iBio to Participate in the Cantor 2021 Virtual Global Healthcare Conference

Rhea-AI Summary

iBio, Inc. (NYSEA:IBIO), a leader in biopharmaceuticals, announced that its Chairman & CEO, Tom Isett, and CSO, Martin Brenner, will engage in a fireside chat at the Cantor Virtual Global Healthcare Conference on September 27, 2021, at 10:00 a.m. ET. This event will focus on the innovative FastPharming Manufacturing System® and the company’s advancements in biopharmaceutical development. The chat will be broadcast live on the company’s website and archived for future access.

BRYAN, Texas, Sept. 20, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System^®, today announced that the Company’s Chairman & CEO, Tom Isett, and its CSO, Martin Brenner, DVM, Ph.D., will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 10:00 a.m. Eastern Time.

The fireside chat will be broadcast live and archived on the Company's website at www.ibioinc.com under "News & Events" in the Investors section.

About iBio, Inc.

iBio is a developer of next-generation biopharmaceuticals and a pioneer in sustainable, plant-based biologics manufacturing. Its FastPharming System^® combines vertical farming, automated hydroponics, and novel glycosylation technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins. iBio is developing proprietary biopharmaceuticals for the treatment of cancers, as well as fibrotic and infectious diseases. The Company’s subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services along with Glycaneering Development Services™ for advanced recombinant protein design. For more information, visit www.ibioinc.com.

Contact:

Stephen Kilmer
iBio, Inc.
Investor Relations
(646) 274-3580
skilmer@ibioinc.com

FAQ

When is iBio's fireside chat at the Cantor Virtual Global Healthcare Conference?

iBio's fireside chat is scheduled for September 27, 2021, at 10:00 a.m. Eastern Time.

Who will represent iBio at the Cantor Virtual Global Healthcare Conference?

iBio's Chairman & CEO, Tom Isett, and CSO, Martin Brenner, will represent the company.

Where can I watch iBio's fireside chat?

The fireside chat will be broadcast live and archived on iBio's website under 'News & Events' in the Investors section.

What is the focus of iBio's discussions at the conference?

The discussions will focus on iBio's FastPharming Manufacturing System® and its biopharmaceutical innovations.

What does iBio, Inc. specialize in?

iBio specializes in the development of next-generation biopharmaceuticals and sustainable, plant-based biologics manufacturing.